An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I)

NCT04453085 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Mucopolysaccharidosis I

Interventions

DRUG: JR-171

Sponsor

JCR Pharmaceuticals Co., Ltd.